Related Experiment Videos
Midazolam: an effective intravenous agent for seizure control
1Department of Emergency Medicine, Fremantle Hospital, Western Australia.
Archives of Emergency Medicine
|September 1, 1987
Summary
Midazolam meleate effectively treated seizures, including status epilepticus, in 20 patients. This water-soluble benzodiazepine rapidly terminated seizures with no observed complications, highlighting its emergency treatment potential.
Area of Science:
- Pharmacology
- Neurology
- Emergency Medicine
Background:
- Seizures, particularly status epilepticus, represent a critical neurological emergency.
- Effective and rapid-acting anticonvulsant medications are essential for emergency seizure management.
- Midazolam, a water-soluble benzodiazepine, has potential applications in acute seizure control.
Purpose of the Study:
- To evaluate the efficacy and safety of intravenous midazolam meleate in patients experiencing seizures.
- To determine the effectiveness of midazolam in terminating active seizure episodes, including status epilepticus.
Main Methods:
- Intravenous administration of midazolam meleate (2.5-15 mg) to 20 patients with active seizures.
- Inclusion of patients experiencing status epilepticus (12 out of 20).
- Monitoring for seizure termination and adverse complications.
Main Results:
- Midazolam rapidly terminated seizures in all 20 patients.
- No complications were reported following midazolam administration.
- Alcohol-withdrawal seizures were identified as a common etiology.
- Many patients were on anticonvulsants, but few maintained therapeutic levels.
Conclusions:
- Intravenous midazolam meleate is a highly effective agent for the emergency treatment of seizures.
- The drug demonstrates a favorable safety profile for acute seizure management.
- Midazolam offers a rapid and effective solution for terminating seizures in an emergency setting.